Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:628767.
doi: 10.1155/2015/628767. Epub 2015 Jul 26.

Adult Mesenchymal Stem Cells: When, Where, and How

Affiliations
Review

Adult Mesenchymal Stem Cells: When, Where, and How

Arnold I Caplan. Stem Cells Int. 2015.

Abstract

Adult mesenchymal stem cells (MSCs) have profound medicinal effects at body sites of tissue injury, disease, or inflammation as either endogenously or exogenously supplied. The medicinal effects are either immunomodulatory or trophic or both. When to deliver these mediators of regeneration, where, and by what delivery apparatus or mechanism will directly determine their medical efficacy. The MSCs help manage the innate regenerative capacity of almost every body tissue and the MSCs have only recently been fully appreciated. Perhaps the most skilled physician-manager of the body's innate regenerative capacity is in orthopedics where the vigorous regeneration and repair capacity of bone through local MSCs-titers is expertly managed by the orthopaedic physician. The challenge is to extend MSCs expertise to address other tissue dysfunctions and diseases. The medicine of tomorrow will encompass optimizing the tissues' intrinsic regenerative potential through management of local MSCs.

PubMed Disclaimer

References

    1. Caplan A. I., Haynesworth S. E. Human mesenchymal stem cells. Patent no. 5,486,359, 1996.
    1. Caplan A. I., Haynesworth S. E. Monoclonal Antibodies for Human Osteogenic Cell Surface Antigens. Patent no. 5,643,736, 1997. - PubMed
    1. Caplan A. I. Cell delivery and tissue regeneration. Journal of Controlled Release. 1990;11(1–3):157–165. doi: 10.1016/0168-3659(90)90129-h. - DOI
    1. Caplan A. I. The mesengenic process. Clinics in Plastic Surgery. 1994;21(3):429–435. - PubMed
    1. Crisan M., Yap S., Casteilla L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301–313. doi: 10.1016/j.stem.2008.07.003. - DOI - PubMed

LinkOut - more resources